Bajaj Healthcare Ltd — earnings calls
1 quarter summarised from transcripts filed with the exchange, every statement cited. Newest first.
Q1 FY27 earnings call
Bajaj Healthcare reported Q1 FY27 revenue of Rs 165.6 crore, up 11.3% year-on-year, with EBITDA margin expanding to 17.8%. Management described progress on new manufacturing facilities for peptides and oncology APIs, first-mover regulatory approvals in CNS therapy, and a reduction in debt-to-equity ratio. Domestic API business grew 27% year-on-year and was highlighted as the key growth driver for the quarter.